GlassScriptPhysician profile
Anthony A Vasile
NPI 1821071820
$4,289.41
in general payments reported to CMS, 2019-2025
27 companies · $318 in 2025
The $318 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $620 · 2020: $727 · 2021: $901 · 2022: $934 · 2023: $789 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,058 · Education: $49.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,057.53 |
| Education | $49.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,066.79 | 2020-2023 | Breztri, Tezspire, Fasenra |
| Glaxosmithkline, LLC. | $1,042.83 | 2019-2023 | Trelegy Ellipta |
| Zoll Respicardia, INC. | $412.95 | 2023-2025 | Remede System |
| Jazz Pharmaceuticals INC. | $195.21 | 2019-2023 | Xywav |
| Boehringer Ingelheim Pharmaceuticals, INC. | $192.22 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $150.31 | 2019-2023 | Dupixent |
| Mylan Specialty L.P. | $149.28 | 2020-2023 | Yupelri |
| Genzyme Corporation | $129.38 | 2019-2023 | |
| Inspire Medical Systems, INC. | $127.70 | 2019 | |
| United Therapeutics Corporation | $109.62 | 2020-2021 | |
| Harmony Biosciences LLC | $103.07 | 2020-2023 | Wakix |
| Pulmonx Corporation | $66.33 | 2019 | |
| Grifols USA, LLC | $60.69 | 2020-2021 | |
| Advanced Respiratory, INC | $60.05 | 2020 | |
| Paratek Pharmaceuticals, INC. | $55.86 | 2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $54.38 | 2019-2021 | |
| Axsome Therapeutics, INC. | $49.21 | 2023 | Sunosi |
| Actelion Pharmaceuticals US, INC. | $40.49 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $34.42 | 2022 | |
| Amgen INC. | $33.05 | 2022-2023 | Tezspire |
| Mallinckrodt Enterprises LLC | $32.49 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.76 | 2023 | Glassia |
| Ani Pharmaceuticals, INC. | $27.33 | 2023 | Purified Cortrophin Gel |
| Eisai INC. | $18.86 | 2020 | |
| Genentech USA, INC. | $18.34 | 2020 | |
| Sunovion Pharmaceuticals INC. | $14.00 | 2019 | |
| Baxter Healthcare | $12.79 | 2023 | Hillrom - Life 2000 Ventilation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Vasile listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.